Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorapaxar in the human endotoxemia model
2016-000309-34Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of vorapaxar in endotoxemia, sponsored by Medical University of Vienna. Primary endpoint: prothrombin fragments F1+2. Started May 2016; status: completed.
02
Drugs
vorapaxar
03
Conditions
endotoxemia
Beyond the preview
Go deeper on 2016-000309-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000309-34.